Efficacy and safety of leflunomide in th
β
J. Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F. Rosen; Frank Behrens;
π
Article
π
2004
π
John Wiley and Sons
π
English
β 157 KB
π 2 views
## Abstract ## Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, and small studies have suggested similar efficacy in PsA. We undertook this doubleβblind,